Archive for 2003

More regulations for biotech products aren’t necessary, FDA says

More regulations for biotech products aren’t necessary, FDA says Genetically engineered foods from crops that have already been reviewed and approved by two government agencies shouldn’t have to jump through a third regulatory hoop at the Food and Drug Administration, an FDA official told Congress Tuesday.


Click here for reuse options!
Copyright 2003 Biotechblog

Pfizer unveils anti-smoking drug

Pfizer unveils anti-smoking drug Pfizer Inc. introduced a new anti-smoking drug Tuesday that could become one of its biggest selling products.


Click here for reuse options!
Copyright 2003 Biotechblog

New Drug Rules Aim To Speed Generics

New Drug Rules Aim To Speed Generics President Bush today announced new regulations to hasten the pace at which generic drugs are brought to market, a measure the administration says will save $3.5 billion annually after it takes effect Aug. 18.


Click here for reuse options!
Copyright 2003 Biotechblog

RNAi Firms Stake Their Claims

RNAi Firms Stake Their Claims First there was gene splicing. Next came monoclonal antibodies. And now, RNA interference, or gene silencing, has taken the scientific community by storm. Reportedly, RNA interference technology has revolutionized the practice of molecular biology – and the excitement it has generated continues to mount


Click here for reuse options!
Copyright 2003 Biotechblog

More U.S. Investment in Biotech Needed, USAID Chief Says

More U.S. Investment in Biotech Needed, USAID Chief Says The United States and the international community should continue to invest more in the development of new agricultural technologies — including biotechnology — to prevent millions more Africans from becoming malnourished and vulnerable to disease and infection, says Andrew Natsios, administrator of the U.S. Agency for […]


Click here for reuse options!
Copyright 2003 Biotechblog

Biotech Investors: When Will They Ever Learn?

Biotech Investors: When Will They Ever Learn? Investors should get a grip on reality. Many small companies that were lifted on the latest news are strapped for cash and pursuing risky science that will take years to bear fruit. Even for big players, good trial data on a drug don’t guarantee Food & Drug Administration […]


Click here for reuse options!
Copyright 2003 Biotechblog

Drug ads deliver a few side effects

Drug ads deliver a few side effects Drug companies tripled their advertising budgets in recent years to acquaint American consumers with things like acid reflux disease, depression, erectile dysfunction, and even toenail fungus, a marketing blitz that accounted for roughly 12 percent of the growth in national prescription drug spending in 2000, according to a […]


Click here for reuse options!
Copyright 2003 Biotechblog

Biotech Industry Could Turn Profitable This Decade

Biotech Industry Could Turn Profitable This Decade The U.S. biotechnology industry could turn a net profit within five to seven years if it gets a break on both regulatory and technological fronts, the author of a new report on the industry said.


Click here for reuse options!
Copyright 2003 Biotechblog

Biotech firms eye rally hungrily

Biotech firms eye rally hungrily With so many firms in dire financial straits, many executives are desperately hoping that this spring’s rally in biotech stocks will give way to a turnaround that will allow them to raise the cash they need to survive.


Click here for reuse options!
Copyright 2003 Biotechblog

%d bloggers like this: